Affiliation:
1. Department of Pediatrics and Medical Ethics, University of Utah, Salt Lake City, Utah
Abstract
Newborn metabolic screening represents the largest application of genetic testing in medicine. As new technologies are developed, the number of conditions amenable to newborn screening (NBS) will continue to expand. Despite the scope of these programs, the evidence base for a number of NBS applications remains relatively weak. This article briefly reviews the evidence base for several conditions. The article then develops a proposal for a structured sequence of research protocols to evaluate potential applications for NBS before their formal implementation in public health programs. Such a framework for research will require collaboration between states and the federal government, a collaboration that is emerging through recent federal legislation and funding.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference61 articles.
1. American Academy of Pediatrics/Health Resources and Services Administration Newborn Screening Task Force. Serving the family from birth to the medical home: newborn screening: a blueprint for the future: a call for a national agenda on state newborn screening programs. Pediatrics. 2000;106:389–422
2. Begley S. Research involving tests on newborns highlights need for stricter ethics. Wall Street Journal. May 3, 2002
3. Taylor HA, Wilfond BS. Ethical issues in newborn screening research: lessons from the Wisconsin cystic fibrosis trial. J Pediatr. 2004;145:292–296
4. New York State Task Force on Life and the Law. Genetic Testing and Screening in the Age of Genomic Medicine. Albany, NY: Health Education Services; 2000:143
5. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348:2304–2312
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献